Amgen Inc. (AMG.F)
Develops and manufactures medicines to treat diseases like cancer, arthritis, and osteoporosis.
343.50+0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+31.6%
The outlook
AMG.F is trading near its 52-week highs and sitting above both its 50- and 200-day moving averages, reflecting sustained upward momentum. The stock carries a trailing P/E of 27.2, indicating a premium valuation relative to current earnings. Analyst sentiment leans bullish overall, though the stock's position near yearly highs leaves limited room before resistance levels.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range97% of the way from its 52-week low to high
Market cap
$185.39B
52-wk high
347.00
52-wk low
230.00
50-day avg
306.48
200-day avg
295.49
Trailing P/E
27.2